跳至主要内容
临床试验/CTRI/2016/03/006769
CTRI/2016/03/006769招募中1 期

Pharmaceutical standardization of saptarangyadi vati prepared by two methods and their comparative effect on MADHUMEHA(TYPE-2 DIABETIS MELLITUS)

Institute ipgt ra0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having classical symptoms of Type II D.M. (Madhumeha) will be selected from O.P.D. and I.P.D. of I.P.G.T. & R.A. Hospital, Jamnagar.
  • Both the Genders having age between 30 to 70 years.
  • Patients having Fasting glucose level >= 126 mg/dl and Post prandial glucose level >= 200 mg/dl.

排除标准

  • Patients IDDM.
  • Uncontrolled cases of Diabetes
  • Patients having chronic complications of Diabetes
  • Microvascular: Retinopathy, Neuropathy & Nephropathy.
  • Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
  • Other chronic debilitating diseases like Tuberculosis, STD etc.

研究者

发起方
Institute ipgt ra

相似试验